Assessment of the Duration of Protection in <i>Campylobacter jejuni</i> Experimental Infection in Humans
David R. Tribble(Uniformed Services University of the Health Sciences), A. Louis Bourgeois(Program for Appropriate Technology in Health), John D. Clements(Tulane University), Edward F. Burg(Naval Medical Research Command), Michael L. Oplinger(United States Department of the Army), Lisa Applebee(Naval Medical Research Command), Daniel A. Scott(Naval Medical Research Command), David M. Rollins(Naval Medical Research Command), Anthony P. Moran(Ollscoil na Gaillimhe – University of Galway), Richard I. Walker(Program for Appropriate Technology in Health), F. Trespalacios(United States Department of the Army), Shahida Baqar(Naval Medical Research Command), Paul Gibbs(United States Department of the Army)
Cited by 106
Related Papers
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
|Nature|1987|503
Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity
|Infection and Immunity|1996|432
Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report
|Journal of Travel Medicine|2017|265
IMPACT OF ILLNESS AND NON-COMBAT INJURY DURING OPERATIONS IRAQI FREEDOM AND ENDURING FREEDOM (AFGHANISTAN)
|American Journal of Tropical Medicine and Hygiene|2005|237